Skip to main content
Home
  • Company
    • History
    • Leadership
    • Clients and Collaborators
    • By the Numbers
  • Capabilities
    • Emmes - CRO
      • Specialties
        • Vaccines & Infectious Diseases
        • Ophthalmology
        • Clinical Neuroscience
        • Rare Disease
        • Cell & Gene Therapy
        • Government
      • Additional Specialties
        • Hematology
        • Oncology
        • Maternal & Child Health
        • Medical Devices
      • Clinical Services
        • Biostatistics
        • Clinical Data Management
        • Clinical Research Services
        • Clinical Trial Management
        • Global Regulatory Affairs
        • Pharmacovigilance & Medical Monitoring
    • Veridix - Tech & AI
      • eClinical Platform
        • EDC
        • Decentralized Clinical Trials
        • Health Navigator
        • RTSM
        • eCOA / ePRO
      • AI Agents
        • Biostats and Analysis Agent
        • Data Management Agent
        • Document Authoring
      • GlobalTrace
      • Analytics & Reporting
        • Clinical Pipelines
        • VERA
  • Resources
    • Newsroom
    • Blog
  • Careers
  • Contact
    • Locations
    • Contact Us

Breadcrumb

  1. Emmes Group

A Randomized, Controlled Trial of Antioxidants and Zinc and the Impact on Cognition in the Elderly: The AREDS Ancillary Trial

Go back to Resources

A Randomized, Controlled Trial of Antioxidants and Zinc and the Impact on Cognition in the Elderly: The AREDS Ancillary Trial

Authors:

Location:

Go back to Resources

A Prospective, randomized, double blind, multicenter trial of early (7 day) corticosteroid cessation vs long term low dose corticosteroid therapy under tacrolimus and mycopheonlate mofetil therapy with antibody induction

Go back to Resources

A Prospective, randomized, double blind, multicenter trial of early (7 day) corticosteroid cessation vs long term low dose corticosteroid therapy under tacrolimus and mycopheonlate mofetil therapy with antibody induction

Authors:

Go back to Resources

A prospective, randomized, trial of the effect of multi-center trial of antibody induction in simultaneous pancreas and kidney transplantation: three year results

Go back to Resources

A prospective, randomized, trial of the effect of multi-center trial of antibody induction in simultaneous pancreas and kidney transplantation: three year results

Authors:

Secondary:

Volume:

Pagination:

Go back to Resources

(Collaborative Islet Transplant Registry [CITR])

Go back to Resources

(Collaborative Islet Transplant Registry [CITR])

Authors:

Secondary:

Volume:

Go back to Resources

Vaccination success rate and reaction profile with diluted and undiluted smallpox vaccine

Go back to Resources

Vaccination success rate and reaction profile with diluted and undiluted smallpox vaccine

Authors:

Secondary:

Volume:

Pagination:

Go back to Resources

Uveitis therapy: a phase II study using subcutaneously administered daclizumab

Go back to Resources

Uveitis therapy: a phase II study using subcutaneously administered daclizumab

Authors:

Location:

Go back to Resources

Untitled

Go back to Resources

Untitled

Authors:

Location:

Go back to Resources

The relationship of Tacrolimus blood levels to efficacy and adverse events in kidney transplant patients treated with mycophenolate mofetil (MMF) or Sirolimus

Go back to Resources

The relationship of Tacrolimus blood levels to efficacy and adverse events in kidney transplant patients treated with mycophenolate mofetil (MMF) or Sirolimus

Authors:

Location:

Go back to Resources

The Effect of Ruboxistaurin (RBX), a PKC b Inhibitor, on Visual Acuity (VA) Loss Due to Diabetic Macular Edema (DME)

Go back to Resources

The Effect of Ruboxistaurin (RBX), a PKC b Inhibitor, on Visual Acuity (VA) Loss Due to Diabetic Macular Edema (DME)

Authors:

Location:

Go back to Resources

The Advanced Glaucoma Intervention Study (AGIS): 14. Distinguishing Progression of Glaucoma from Visual Field Fluctuations

Go back to Resources

The Advanced Glaucoma Intervention Study (AGIS): 14. Distinguishing Progression of Glaucoma from Visual Field Fluctuations

Authors:

Secondary:

Volume:

Pagination:

URL:

Keywords:

Abstract:

Go back to Resources

Pagination

  • First page « First
  • Previous page ‹ Previous
  • …
  • Page 143
  • Page 144
  • Page 145
  • Page 146
  • Current page 147
  • Page 148
  • Page 149
  • Page 150
  • Page 151
  • …
  • Next page Next ›
  • Last page Last »
Subscribe to
Emmes Group

Delivering Global Health
Impact Through People,
Science and Technology

Main navigation
  • Company
    • History
    • Leadership
    • Clients and Collaborators
    • By the Numbers
  • Capabilities
    • Emmes - CRO
    • Veridix - Tech & AI
  • Resources
    • Newsroom
    • Blog
  • Careers
  • Contact
    • Locations
    • Contact Us
linkedin X

Copyright ©, The Emmes Company, LLC

Footer
  • Cookie Policy
  • External Privacy Notice
  • FCOI
  • Emmes EU-U.S. Data Privacy Framework
  • Purchasing Terms and Conditions
  • ISO Certification